CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
NANOTEST aims to assess the safety of nanoparticles used in medical diagnostics through comprehensive in vitro and in silico testing. The project will evaluate their toxicological profiles and interactions with biological systems to ensure human health safety.
Nanoparticles (NP) have unique, potentially beneficial properties, but their possible impact on human health has not been adequately assessed.
The main goal of this proposal is to develop alternative high-throughput testing strategies using in vitro and in silico methods to assess the toxicological profile of NP used in medical diagnostics.
Our specific aims are to: 1.
Define NP properties and fully characterize NP to be used 2.
Study NP interactions with molecules, cells and organs and develop…
STIFTELSEN NILU
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Switzerland, Lausanne
Type: Public body
Activity type: Public bodies (excluding Research Organisations and Secondary or Higher Education Establishments)
SME: No
France, Paris
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
UNIVERSITY HOSPITALS BRISTOL AND WESTON NHS FOUNDATION TRUST
United Kingdom, Bristol
Type: Research institute
Activity type: Research Organisations
SME: No
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
Guests see up to 5 sectors.
